Squaric acid dibutyl ester - Squarex

Drug Profile

Squaric acid dibutyl ester - Squarex

Alternative Names: SADBE; SQX 770

Latest Information Update: 06 Jul 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Squarex
  • Class Antivirals; Esters; Immunotherapies; Small molecules
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Herpes labialis
  • Preclinical Herpes simplex virus infections

Most Recent Events

  • 06 Jul 2017 Chemical structure information added
  • 01 Jun 2017 Preclinical trials in Herpes simplex virus infections in USA (Topical)
  • 24 May 2017 Squarex has patent protection for Squaric acid dibutyl ester
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top